Marburg I polymorphism of factor VII–activating protease is associated with idiopathic venous thromboembolism

Blood ◽  
2005 ◽  
Vol 105 (4) ◽  
pp. 1549-1551 ◽  
Author(s):  
Berthold Hoppe ◽  
Farzaneh Tolou ◽  
Hartmut Radtke ◽  
Holger Kiesewetter ◽  
Thomas Dörner ◽  
...  
Keyword(s):  
Venous Thromboembolism ◽  
Odds Ratio ◽  
Independent Risk Factor ◽  
Case Control Study ◽  
Case Control ◽  
Factor Vii ◽  
Healthy Controls ◽  
History Of ◽  
Control Study

AbstractThe factor VII–activating protease (FSAP) variant Marburg I is known to attenuate the profibrinolytic system in vitro and was recently shown to be a significant predictor for the evolution and progression of carotid stenosis. The objective of this case-control study was to assess FSAP Marburg I's role in the occurrence of venous thromboembolism (VTE). The frequency of FSAP Marburg I was significantly increased in patients with a history of VTE (17 of 213 patients, 8.0%, P = .014) or idiopathic VTE (12 of 103 patients, 11.7%, P = .002) compared to healthy controls (5 of 213 controls, 2.3%). Logistic regression analysis confirmed FSAP Marburg I to be an independent risk factor for VTE (odds ratio, 3.5; 95% confidence interval [CI], 1.2-10.0) and idiopathic VTE (odds ratio, 6.2; 95% CI, 2.0-18.9).

Warfarin prophylaxis and venous thromboembolism in the first 5 days following hip and knee arthroplasty

2004 ◽  
Vol 92 (11) ◽  
pp. 1012-1017 ◽  
Author(s):  
Amir Jaffer ◽  
Jason Hurbanek ◽  
Nariman Morra ◽  
Daniel Brotman
Keyword(s):  
Venous Thromboembolism ◽  
Knee Arthroplasty ◽  
Odds Ratio ◽  
Case Control Study ◽  
Secondary Analysis ◽  
Case Control ◽  
Antithrombotic Effects ◽  
Hip And Knee Arthroplasty ◽  
Subcutaneous Enoxaparin ◽  
Control Study

SummaryMany orthopaedic surgeons use warfarin to prevent venous thromboembolism (VTE) following hip or knee arthroplasty. Since warfarin’s antithrombotic effects are delayed, we hypothesized that early VTE (occurring within 5 days post-operatively) would be more common in arthroplasty patients receiving warfarin monotherapy compared to those receiving enoxaparin. We performed a secondary analysis of a case-control study examining risk factors for post-operative thrombosis in postmenopausal women. We defined cases as patients who were diagnosed with thrombosis within 5 days of surgery. Controls without thrombosis were matched with cases by age, surgeon, year of surgery and surgical joint. 84 women with early post-operative thrombosis (cases) were matched with 206 controls. 18 cases (21.4%) had been prescribed warfarin monotherapy, compared with 7 controls (3.4%). 58 (69.1%) cases and 195 (94.7%) controls had been prescribed subcutaneous enoxaparin 30 mg twice daily, starting 12-24 hours after surgery. The odds ratio for any early thrombosis in patients receiving warfarin as opposed to enoxaparin 30 mg twice daily was 8.6 (p<0.0001). For proximal thrombosis, the odds ratio was 11.3 (p<0.0001). Multivariate analysis did not alter these findings. Warfarin’s delayed antithrombotic effects may not provide adequateVTE prophylaxis in the immediate post-operative setting. We suggest caution in employing warfarin monotherapy following joint arthroplasty.

Age May Modify the Relationship between Factor V Leiden Mutation - but Not G20210A Prothrombin Gene Variation - and Idiopathic Venous Thromboembolism: An Hospital-Based Case-Control Study.

Blood ◽  
2004 ◽  
Vol 104 (11) ◽  
pp. 4052-4052
Author(s):  
Gregoire Le Gal ◽  
Karine Lacut ◽  
Francis Couturaud ◽  
Emmanuel Oger ◽  
Dominique Mottier
Keyword(s):  
Risk Factor ◽  
Venous Thromboembolism ◽  
Odds Ratio ◽  
Case Control Study ◽  
Factor V Leiden ◽  
Case Control ◽  
Factor V ◽  
Gene Variation ◽  
Prothrombin Gene ◽  
Control Study

Abstract Introduction: Factor V Leiden is the most common inherited risk factor for venous thromboembolism (VTE). A four- to sevenfold increased risk of VTE for the heterozygous state has been reported by numerous epidemiological studies but most of them did not include patients over 70 years. Surprisingly, we found in a previous study no association between Factor V Leiden and VTE in patients over 70 years. Methods Therefore we conducted a large hospital-based matched case-control study to test the hypothesis of an interaction between age and the factor V mutation, as well as G20210A prothrombin gene variation. Results: We analysed 392 patients experiencing VTE not related to a major acquired risk factor and their matched controls. Factor V Leiden was not associated with VTE in patients aged 80 years and over: odds ratio 0.8 (95%CI 0.2-3.4). There was a significant interaction between age and the mutation for VTE risk (p=0.03). Conversely, the association between the G20210A variant and VTE was consistent across age-groups: odds ratio 2.8 (95%CI 1.4–5.8). In conclusion, age may modify the relation between factor V Leiden and VTE. The prevalence of the factor V mutation decreased with increasing age among patients with VTE but not among controls.

A case-control study of risk factors of chronic venous ulceration in patients with varicose veins

2017 ◽  
Vol 33 (1) ◽  
pp. 60-67 ◽  
Author(s):  
Gohar Abelyan ◽  
Lusine Abrahamyan ◽  
Gayane Yenokyan
Keyword(s):  
Risk Factors ◽  
Confidence Interval ◽  
Odds Ratio ◽  
Case Control Study ◽  
Varicose Veins ◽  
Case Control ◽  
Sitting Time ◽  
Venous Ulceration ◽  
History Of ◽  
Control Study

Background/objectives Venous ulcers carry psychological and high financial burden for patients, causing depression, pain, and limitation of mobility. The study aimed to identify factors associated with an increased risk of venous ulceration in patients with varicose veins in Armenia. Methods A case-control study design was utilized enrolling 80 patients in each group, who underwent varicose treatment surgery in two specialized surgical centers in Armenia during 2013–2014 years. Cases were patients with varicose veins and venous leg ulcers. Controls included patients with varicose veins but without venous leg ulcers. Data were collected using interviewer-administered telephone interviews and medical record abstraction. Multiple logistic regression analysis was used to identify the risk factors of venous ulceration. Results There were more females than males in both groups (72.5% of cases and 85.0 % of controls). Cases were on average older than controls (53.9 vs. 39.2 years old, p ≤ 0.001). After adjusting for potential confounders, the estimated odds of developing venous ulcer was higher in patients with history of post thrombotic syndrome (odds ratio = 14.90; 95% confidence interval: 3.95–56.19; p = 0.001), with higher average sitting time (odds ratio = 1.32 per hour of sitting time; 95% confidence interval: 1.08–1.61; p = 0.006), those with reflux in deep veins (odds ratio = 3.58; 95% confidence interval: 1.23–10.31; p = 0.019) and history of leg injury (odds ratio = 3.12; 95% confidence interval: 1.18–8.23; p = 0.022). Regular exercise in form of walking (≥5 days per week) was found to be a protective factor from venous ulceration (odds ratio = 0.26; 95% confidence interval: 0.08–0.90; p = 0.034). Conclusion We found that reflux in deep veins, history of leg injury, history of post thrombotic syndrome, and physical inactivity were significant risk factors for venous ulceration in patients with varicose veins, while regular physical exercise mitigated that risk. Future studies should investigate the relationships between the duration and type of regular exercise and the risk of venous ulceration to make more specific recommendations on preventing ulcer development.

scholarly journals 2013 multistate outbreaks of Cyclospora cayetanensis infections associated with fresh produce: focus on the Texas investigations

2015 ◽  
Vol 143 (16) ◽  
pp. 3451-3458 ◽  
Author(s):  
F. ABANYIE ◽  
R. R. HARVEY ◽  
J. R. HARRIS ◽  
R. E. WIEGAND ◽  
L. GAUL ◽  
...  
Keyword(s):  
Odds Ratio ◽  
Case Control Study ◽  
Case Control ◽  
International Travel ◽  
The Other ◽  
Annual Number ◽  
Temporal Association ◽  
Illness Onset ◽  
History Of ◽  
Control Study

SUMMARYThe 2013 multistate outbreaks contributed to the largest annual number of reported US cases of cyclosporiasis since 1997. In this paper we focus on investigations in Texas. We defined an outbreak-associated case as laboratory-confirmed cyclosporiasis in a person with illness onset between 1 June and 31 August 2013, with no history of international travel in the previous 14 days. Epidemiological, environmental, and traceback investigations were conducted. Of the 631 cases reported in the multistate outbreaks, Texas reported the greatest number of cases, 270 (43%). More than 70 clusters were identified in Texas, four of which were further investigated. One restaurant-associated cluster of 25 case-patients was selected for a case-control study. Consumption of cilantro was most strongly associated with illness on meal date-matched analysis (matched odds ratio 19·8, 95% confidence interval 4·0–∞). All case-patients in the other three clusters investigated also ate cilantro. Traceback investigations converged on three suppliers in Puebla, Mexico. Cilantro was the vehicle of infection in the four clusters investigated; the temporal association of these clusters with the large overall increase in cyclosporiasis cases in Texas suggests cilantro was the vehicle of infection for many other cases. However, the paucity of epidemiological and traceback information does not allow for a conclusive determination; moreover, molecular epidemiological tools for cyclosporiasis that could provide more definitive linkage between case clusters are needed.

A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism

Blood ◽  
2004 ◽  
Vol 104 (12) ◽  
pp. 3631-3634 ◽  
Author(s):  
Armando Tripodi ◽  
Veena Chantarangkul ◽  
Ida Martinelli ◽  
Paolo Bucciarelli ◽  
Pier Mannuccio Mannucci
Keyword(s):  
Venous Thromboembolism ◽  
Partial Thromboplastin Time ◽  
Odds Ratio ◽  
Case Control Study ◽  
Coagulation Factors ◽  
Case Control ◽  
Activated Partial Thromboplastin Time ◽  
Simple Test ◽  
Coagulation Time ◽  
Control Study

Hypercoagulability due to high coagulation factors XI, VIII, IX, II, and fibrinogen is recognized as a risk factor of venous thromboembolism (VTE). These factors are cumulatively explored by the activated partial thromboplastin time (APTT). To test the hypothesis that a short APTT increases the risk of VTE, a case-control study was carried out in 605 patients referred for thrombophilia testing after documented VTE and in 1290 controls. Median APTT ratio (coagulation time of test-to-reference plasma) values were 0.97 (range: 0.75-1.41) for patients and 1.00 (range: 0.72-1.33) for controls (P &lt; .001). In patients who had an APTT ratio smaller than the fifth percentile of the distribution in controls, the odds ratio (OR) for VTE was 2.4 (95% confidence interval [CI]: 1.7-3.6) and was independent of inherited thrombophilic abnormalities. Further statistical analyses in 193 patients and 259 controls for whom factor VIII (FVIII) levels were available showed a decrease of the OR from 2.7 (95% CI: 1.4-5.3) to 2.1 (95% CI: 1.0-4.2), indicating that the risk was only partially mediated by high FVIII levels. In conclusion, hypercoagulability detected by a shortened APTT is independently associated with VTE. This inexpensive and simple test should be considered in the evaluation of the risk of VTE.

scholarly journals A Single Nucleotide Polymorphism in the MMP9 Promoter Affects Lung Cancer and Clinicopathological Properties in Iranian Population

2021 ◽  
Vol 2 (12) ◽  
pp. 1274-1282
Author(s):  
Somayeh Taghvaei ◽  
Leila Saremi ◽  
Majid Motovali-bashi
Keyword(s):  
Lung Cancer ◽  
Family History ◽  
Cancer Patients ◽  
Odds Ratio ◽  
Case Control Study ◽  
Positive Family History ◽  
Case Control ◽  
Healthy Controls ◽  
Lung Cancer Patients ◽  
Control Study

Background: Lung cancer is the most common cancer with 2,206,771 new cases in 2020 in worldwide. MMP9 is a member of matrix metalloproteinase family that is also known as gelatinase B or IV type collagenase (92KD). MMP9 through degrading of Extracellular Matrix (ECM) and releasing of growth factors has fundamental role in the tumorigenesis process. The C -1562 T SNP in the MMP9 promoter increases MMP9 expression and susceptibility to lung cancer. Then, the aim of this present case-control study was to investigate whether genetic variations of the MMP9 gene may constitute markers for lung cancer risk in males and in positive family history people in Iran. Methods: This is a case-control study including 120 lung cancer patients and 100 healthy controls. Polymorphism in the C -1562 T region was genotyped by PCR-RFLP assay. Odds Ratio (ORs) and 95% Confidence Intervals (CIs) were estimated by chi-square test from comparison of genotypes between lung cancer patients and healthy controls, using SPSS version 26.0. T-test and Image J software was also used. Results: The distribution of C-1562T genotype was significantly associated with the risk of lung cancer (Odds Ratio [OR] = 2.56, 95% Confidence Interval [CI] = 0.06-23.82). The further stratification analyses shown that males and patients with positive family history may increase risk of lung cancer. Conclusion: Our results indicated that the MMP9 C -1562 T polymorphism affects risk of lung cancer. In addition, men with T allele (OR = 3.94, CI = 1.47-10`.55) and patients with TT genotype and family history (OR = 2.18, CI = 1.03-4.59) exposure to higher risk of lung cancer.

scholarly journals Association Of Food And Drug Allergy With Antituberculosis Drug Related Hepatitis Or Skin Reactions: A Case Control Study

2014 ◽  
Vol 10 (2) ◽  
pp. 48-53
Author(s):  
Dinesh LB Dassanayake ◽  
BKM Asanga Upul ◽  
K Wickramasekara ◽  
SK Ileperuma ◽  
A Siribaddana ◽  
...  
Keyword(s):  
Odds Ratio ◽  
Adverse Reactions ◽  
Case Control Study ◽  
Case Control ◽  
Control Group ◽  
Drug Induced ◽  
Skin Reactions ◽  
Dence Interval ◽  
History Of ◽  
Control Study

Introduction: Anti-tuberculosis drugs can cause adverse reactions including hepatitis and skin reactions. This case control study was aimed at fi nding out whether allergy to drug or food acts as a risk factor for the development of anti-tuberculosis drug induced hepatitis or skin reactions. Patients with tuberculosis on category 1 regimen, who presented to the Teaching Hospital Kandy Sri Lanka, due to anti-tuberculosis drug induced hepatitis or skin reactions from 1st July 2010 to 30th June 2011 were recruited. Methodology: Patients with drug induced hepatitis or skin reactions were grouped as cases and patients who didn’t develop hepatitis or skin reactions during the treatment period were selected as controls. Controls were matched for age, gender, weight, and consumption of alcohol. Cases and controls were inquired for the presence of allergy to drugs or food. Two groups were compared using odds ratio. Results: There were 61 cases [33 (54.1%) males, 28 (45.9%) females] and 61 controls .Ten patients (16.39%) among the cases had allergy to food or drugs while in control group only 2 (03.2%) had allergy. Odds ratio for the development of drug reactions in patients with a history of allergy was 5.8 (confi dence interval 1.2 to 27.6). Conclusion: Patients with allergy to drugs or foods have 5.8 times risk of developing anti-tuberculosis drug induced hepatitis or skin reaction. SAARC Journal of Tuberculosis, Lung Diseases & HIV/AIDS; 2013; X(2); 48-53 DOI: http://dx.doi.org/10.3126/saarctb.v10i2.9714

scholarly journals Interdelivery Interval and Diabetes Mellitus in a Subsequent Pregnancy

2018 ◽  
Vol 36 (10) ◽  
pp. 1039-1044 ◽  
Author(s):  
Annie M. Dude ◽  
Ashley Battarbee ◽  
Lynn M. Yee
Keyword(s):  
Diabetes Mellitus ◽  
Risk Factor ◽  
Odds Ratio ◽  
Independent Risk Factor ◽  
Adjusted Odds Ratio ◽  
Case Control Study ◽  
Case Control ◽  
Subsequent Pregnancy ◽  
Confounding Factors ◽  
Control Study

Objective We determined whether time between deliveries is associated with developing diabetes at the time of a subsequent delivery. Study Design This is a case–control study of women who had two consecutive singleton births at the same institution with no pregestational diabetes in the baseline pregnancy. Cases were defined as women who were diagnosed with any type of diabetes at the time of the subsequent delivery. Controls were defined as women who had no diagnosis of diabetes at the time of the subsequent delivery. Interdelivery interval (IDI) was categorized as < 18, 18 to 60, or > 60 months. Results Of 12,263 women, 4.1% (N = 501) were diagnosed with diabetes at the subsequent delivery. Women with diabetes were more likely to have an IDI of >60 months than women without diabetes (9.0 vs. 4.2%, p < 0.001). After controlling for confounding factors, an IDI > 60 months remained associated with development of pregestational or gestational diabetes by the conclusion of the subsequent pregnancy (adjusted odds ratio = 2.13 compared with an IDI of 18–60 months, 95% confidence interval 1.44–3.15). Conclusion A longer IDI is an independent risk factor for the development of diabetes at the time of a subsequent delivery.

Maternal and foetal placental vascular malperfusion in pregnancies with anti-phospholipid antibodies

Rheumatology ◽  
2020 ◽  
Author(s):  
Arsenio Spinillo ◽  
Camilla Bellingeri ◽  
Chiara Cavagnoli ◽  
Irene De Maggio ◽  
Greta Riceputi ◽  
...  
Keyword(s):  
Case Control Study ◽  
Area Under The Curve ◽  
First Trimester ◽  
Case Control ◽  
Healthy Controls ◽  
Increased Risk ◽  
History Of ◽  
First Trimester Of Pregnancy ◽  
Penalized Logistic Regression ◽  
Control Study

Abstract Objective The objective of the study was to evaluate the rates of pathological placental lesions among pregnant subjects positive for aPL antibodies. Methods We performed a longitudinal case–control study including 27 subjects with primary APS, 51 with non-criteria APS, 24 with aPL antibodies associated with other well-known CTDs enrolled at the end of the first trimester of pregnancy and 107 healthy controls. Results Compared with controls and after correction for multiple comparisons, primary, non-criteria APS and aPL associated to CTD, subjects had lower placental weight, volume and area. After penalized logistic regression analysis to correct for potential confounders, placental lesions suggesting severe maternal vascular malperfusion (MVM) were more common among primary [odds ratio (OR) 11.7 (95% CI 1.3, 108)] and non-criteria APS [OR 8.5 (95% CI 1.6, 45.9)] compared with controls. The risk of foetal vascular malperfusion (FVM) was higher in primary APS [OR 4.5 (95% CI 1.2, 16.4)], aPL associated with CTDs [OR 3.1 (95% CI 1.5, 6.7)] and non-criteria APS [OR 5.9 (95% CI 1.7, 20.1)] compared with controls. Among clinical and laboratory criteria of APS, first trimester aCL IgG &gt;40 UI/ml [OR 4.4 (95% CI 1.3, 14.4)], LA positivity [OR 6.5 (95% CI 1.3, 33.3)] and a history of pre-eclampsia at &lt;34 weeks [OR 32.4 (95% CI 6.5, 161)] were the best independent first trimester predictors of severe MVM [area under the curve 0.74 (95% CI 0.6, 0.87)]. Conclusion Compared with healthy controls, pregnant subjects with aPL antibodies have an increased risk of placental lesions, suggesting MVM and FVM. First-trimester variables such as aCL IgG &gt;40 UI/ml and a history of pre-eclampsia were significant predictors of both severe MVM and FVM.

Sign in / Sign up

Export Citation Format

Share Document